Rationale: Hypoxia regulates the inflammatory-antiinflammatory balanceby thereceptor foradvancedglycationendproducts (RAGE),aversatile sensor of damage-associated molecular patterns. Themultiligand nature of RAGE places this receptor in the midst of chronic inflammatory diseases. Objectives: To characterize the impact of the hypoxia-RAGE pathway on pathogenic airway inflammation preventing effective pathogen clearance in cystic fibrosis (CF) and elucidate the potential role of this danger signal in pathogenesis and therapy of lung inflammation. Methods: We used in vivo and in vitro models to study the impact of hypoxia onRAGE expression andactivity in human and murine CF, the nature of the RAGE ligand, and the impact of RAGE on lung inflammation and antimicrobial resistance in fungal and bacterial pneumonia. Measurements and Main Results: Sustained expression of RAGE and its ligandS100B wasobserved in murine lungandhumanepithelial cells and exerted a proximal role in promoting inflammation inmurine and humanCF, as revealedby functional studies andanalysis of thegenetic variability of AGER in patients with CF. Both hypoxia and infections contributed to the sustained activation of the S100B-RAGE pathway, being RAGE up-regulated by hypoxia and S100B by infection by Tolllike receptors. Inhibiting the RAGE pathway in vivo with soluble (s) RAGE reduced pathogen load and inflammation in experimental CF, whereas sRAGE production was defective in patients with CF. Conclusions: A causal link between hyperactivation of RAGE and inflammation in CF has been observed, such that targeting pathogenic inflammationalleviatedinflammationinCFandmeasurementofsRAGE levels could be a useful biomarker for RAGE-dependent inflammation in patients with CF. Copyright © 2013 by the American Thoracic Society.
Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis / R.G. Iannitti, A. Casagrande, A. De Luca, C. Cunha, G. Sorci, F. Riuzzi, M. Borghi, C. Galosi, C. Massi-Benedetti, T.D. Oury, L. Cariani, M. Russo, L. Porcaro, C. Colombo, F. Majo, V. Lucidi, E. Fiscarelli, G. Ricciotti, C. Lass-Flörl, L. Ratclif, A. Esposito, F.M. De Benedictis, R. Donato, A. Carvalho, L. Romani. - In: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. - ISSN 1073-449X. - 188:11(2013), pp. 1338-1350.
|Titolo:||Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis|
|Parole Chiave:||Cystic fibrosis; Hypoxia; Infections; Inflammation; Rage; Animals; Anoxia; Aspergillosis; Biological Markers; Blotting, Western; Cystic Fibrosis; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Female; Humans; Inflammation Mediators; Italy; Male; Mice; Mice, Inbred C57BL; Middle Aged; Pneumonia; Pseudomonas Infections; Receptors, Immunologic; Respiratory Mucosa; Tissue Culture Techniques; Up-Regulation; Pulmonary and Respiratory Medicine; Critical Care and Intensive Care Medicine|
|Settore Scientifico Disciplinare:||Settore MED/38 - Pediatria Generale e Specialistica|
|Data di pubblicazione:||2013|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1164/rccm.201305-0986OC|
|Appare nelle tipologie:||01 - Articolo su periodico|